Predicting allogeneic blood transfusion use in total joint arthroplasty

Anesthesia and Analgesia

Volumn 99, Issue 4, 2004, Pages 1239-1244

  Rashiq, Saifudin ^a,b   Shah, Meera ^a   Chow, Ava K ^a   O'Connor, Paul J ^a   Finegan, Barry A ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AREA UNDER THE CURVE; ARTHROPLASTY; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; FEMALE; HUMAN; JOINT PROSTHESIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; STATISTICAL MODEL; VALIDATION PROCESS;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANESTHESIA; ARTHROPLASTY, REPLACEMENT; ARTIFICIAL INTELLIGENCE; BLOOD TRANSFUSION; BODY HEIGHT; BODY WEIGHT; DATABASES, FACTUAL; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX FACTORS;

EID: 4644295980     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000132928.45858.92     Document Type: Article

References (16)

1. Commission of Inquiry on the Blood System in Canada. Final report (Krever Commission). Catalog number CP32-62-3-1997E. Ottawa: Canadian Government Publishing, 1997.
2. Marchetti M, Barosi G. Cost-effectiveness of epoetin and autologous blood donation in reducing allogeneic blood transfusions in coronary artery bypass graft surgery. Transfusion 2000;40: 673-81.
3. Savoia HF, Metz J, Maxwell EL, et al. Utilization of preoperative autologous blood donation in elective surgery. Aust N Z J Surg 2002;72:557-60.
4. Husted H, Blond L, Sonne-Holm S, et al. Tranexamic acid reduces blood loss and blood transfusions in primary total hip arthroplasty: a prospective randomized double-blind study in 40 patients. Acta Orthop Scand 2003;74:665-9.
5. Shulman G, Grecula MJ, Hadjipavlou AG. Intraoperative autotransfusion in hip arthroplasty. Clin Orthop Rel Res 2002;396: 119-30.
6. Zarin J, Grosvenor D, Schurman D, Goodman S. Efficacy of intraoperative blood collection and reinfusion in revision total hip arthroplasty. J Bone Joint Surg Am 2003;85:2147-51.
7. Larocque BJ, Gilbert K, Brien WF. Prospective validation of a point score system for predicting blood transfusion following hip or knee replacement. Transfusion 1998;38:932-7.
8. de Andrade JR, Jove M, Landon G, et al. Baseline hemoglobin as a predictor of risk of transfusion and response to Epoetin alfa in orthopedic surgery patients. Am J Orthop 1996;25:533-42.
9. Faris PM, Spence RK, Larholt KM, et al. The predictive power of baseline hemoglobin for transfusion risk in surgery patients. Orthopedics 1999;22:s135-40.
10. Salido JA, Marin LA, Gomez LA, et al. Preoperative hemoglobin levels and the need for transfusion after prosthetic hip and knee surgery: analysis of predictive factors. J Bone Joint Surg Am 2002;84:216-20.
11. Marx RG, Wotherspoon S, Stephens D, Davey JR. Patient factors affecting autologous and allogeneic blood transfusion rates in total hip arthroplasty. Am J Orthop 2001;30:867-71.
12. Grosflam JM, Wright EA, Cleary PD, Katz JN. Predictors of blood loss during total hip replacement surgery. Arthritis Care Res 1995;8:167-73.
13. Rearing EM, Meding JB, Faris PM, Ritter MA. Predictors of transfusion risk in elective knee surgery. Clin Orthop 1998;357:50-9.
14. Cushner FD, Foley I, Kessler D, et al. Blood management in revision total knee arthroplasty. Clin Orthop 2002;404:247-55.
15. D'Ambrosio A, Borghi B, Damato A, et al. Reducing perioperative blood loss in patients undergoing total hip arthroplasty. Int J Artif Organs 1999;22:47-51.
16. Expert Working Group. Guidelines for red blood cell and plasma transfusion for adults and children. Can Med Assoc J 1997;156(11 suppl):S1.